Geron reported $74.25M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Amgen USD 23.23B 2.27B Sep/2026
Bio Techne USD 361.27M 197.57M Sep/2026
Cassava Sciences USD 41.95M 1.79M Sep/2026
Cytokinetics USD 353.42M 171.99M Sep/2026
Exelixis USD 411.88M 49.95M Sep/2026
Genmab DKK 1.14B 38M Jun/2026
Geron USD 74.25M 3.92M Sep/2026
Gilead Sciences USD 12B 982M Sep/2026
Incyte USD 1.44B 125.72M Sep/2026
MacroGenics USD 107.23M 1.58M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Novavax USD 329.84M 729K Sep/2026